Drug Approval | March 29, 2023
Sanofi receives marketing approval for its diabetes drug Soliqua in India
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety
Integration of modern and traditional medicine to facilitate the illness to wellness journey
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
Various healthcare companies are already implementing high-tech solutions into existing healthcare systems.
Subscribe To Our Newsletter & Stay Updated
